NO975636L - Farmasöytisk sammensetning for fremming av osteogenese - Google Patents

Farmasöytisk sammensetning for fremming av osteogenese

Info

Publication number
NO975636L
NO975636L NO975636A NO975636A NO975636L NO 975636 L NO975636 L NO 975636L NO 975636 A NO975636 A NO 975636A NO 975636 A NO975636 A NO 975636A NO 975636 L NO975636 L NO 975636L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
promoting osteogenesis
osteogenesis
promoting
prophylactic
Prior art date
Application number
NO975636A
Other languages
English (en)
Norwegian (no)
Other versions
NO975636D0 (no
Inventor
Tetsuo Hoshino
Hiroya Muranishi
Shigehisa Taketomi
Susumi Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO975636D0 publication Critical patent/NO975636D0/no
Publication of NO975636L publication Critical patent/NO975636L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
NO975636A 1995-06-05 1997-12-04 Farmasöytisk sammensetning for fremming av osteogenese NO975636L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13803695 1995-06-05
JP1168696 1996-01-26
PCT/JP1996/001506 WO1996039134A1 (en) 1995-06-05 1996-06-04 Osteogenetic promoting pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO975636D0 NO975636D0 (no) 1997-12-04
NO975636L true NO975636L (no) 1998-01-28

Family

ID=26347166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975636A NO975636L (no) 1995-06-05 1997-12-04 Farmasöytisk sammensetning for fremming av osteogenese

Country Status (11)

Country Link
EP (1) EP0831808A1 (es)
KR (1) KR19990022514A (es)
AR (1) AR003001A1 (es)
AU (1) AU717260B2 (es)
CA (1) CA2221784A1 (es)
HU (1) HUP9802573A3 (es)
NO (1) NO975636L (es)
NZ (1) NZ308658A (es)
RU (1) RU2188011C2 (es)
TW (1) TW420608B (es)
WO (1) WO1996039134A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008517A2 (en) 1996-08-26 1998-03-05 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
CA2334815A1 (en) * 1998-06-15 1999-12-23 Haruhiko Makino Composition for treating cartilage disease
US6355672B1 (en) 1998-08-07 2002-03-12 Takeda Chemical Industries, Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
CA2340165A1 (en) * 1998-08-12 2000-02-24 Haruhiko Makino Enhancer of cell differentiation induction factor
WO2001089521A1 (fr) * 2000-05-23 2001-11-29 Takeda Chemical Industries, Ltd. Compositions medicinales contenant des derives du tiophene
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
JP4723864B2 (ja) * 2002-12-19 2011-07-13 日本曹達株式会社 Ｏｉｌ／Ｗａｔｅｒ液中乾燥法による農薬マイクロカプセル製剤及びその製造方法
US9814657B2 (en) 2009-04-27 2017-11-14 Premier Dental Products Company Buffered microencapsulated compositions and methods
US8889161B2 (en) 2009-04-27 2014-11-18 Premier Dental Products Company Microencapsulated compositions and methods for tissue mineralization
TWI458503B (zh) * 2013-04-22 2014-11-01 Medical & Pharm Ind Tech & Dev 維生素ｋ微球、其製造方法、用途、及藥劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460488B1 (en) * 1990-05-30 2001-07-11 Takeda Chemical Industries, Ltd. Sulfur-containing heterocyclic compounds
EP0769015B1 (en) * 1994-07-04 2001-03-14 Takeda Chemical Industries, Ltd. Phosphonic acid compounds, their production and use
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use

Also Published As

Publication number Publication date
HUP9802573A2 (hu) 1999-09-28
TW420608B (en) 2001-02-01
KR19990022514A (ko) 1999-03-25
WO1996039134A1 (en) 1996-12-12
AU5845796A (en) 1996-12-24
NZ308658A (en) 1999-10-28
HUP9802573A3 (en) 2000-04-28
CA2221784A1 (en) 1996-12-12
AU717260B2 (en) 2000-03-23
RU2188011C2 (ru) 2002-08-27
NO975636D0 (no) 1997-12-04
AR003001A1 (es) 1998-05-27
EP0831808A1 (en) 1998-04-01

Similar Documents

Publication Publication Date Title
NO20032036L (no) Kombinasjoner av medikamenter (f.eks. klorpromazin og pentamidiner) for behandling av neoplastiske forstyrrelser
DE60020613D1 (de) (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
DE69808130D1 (de) Adamantan-derivate
NO975636L (no) Farmasöytisk sammensetning for fremming av osteogenese
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
BR0011210B1 (pt) mÉtodo e aparelho para esterilizaÇço com ozânio.
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
GB9521608D0 (en) Pharmaceutical composition
NO20012106D0 (no) Middel for behandling av benpatobolisme
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
AU6022400A (en) Exposure method, exposure system, light source, and method of device manufacture
NO953989D0 (no) Nye polysykliske systemer og derivater derav, som neurotransmitter frigivelses-forsökende midler som er anvendbare ved behandling av kognitive sykdommer
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
NO953846L (no) (S)-alfa-fenyl-2-pyridinetanamin (S)-malat og dets anvendelse som legemiddel
NZ332412A (en) use of interleuklin-10 for treating or preventing ischemia-reperfusion injury
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
NO930858D0 (no) Stoff som kan stoppe bloedning, f.eks. ved kirurgiske og dentale inngrep
ES1023694Y (es) Sutura esteril para cirugia estetica.
AU1162592A (en) Low-molecular sulphated poly-beta -2,6-fructofuranosanes and their use in the treatment of degenerative articular ailments
NO961297L (no) Ranitidine og kalsiumkarbonat farmasöytisk produkt
EE04871B1 (et) Dekstrasoksaani kasutamine, produkt ja meetod psoriaasi raviks m?eldud ravimi valmistamiseks

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application